Form D · Other
AME Therapeutics, Inc.
Santa Monica, CA · CIK 0001954975
Offering snapshot reported Nov 17, 2022 · SEC filing
- Reported sold
- $1.07M Offering amount: $1.07M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 8, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 17, 2022 | Initial | $1,072,500 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-465106
Simple Agreements for Future Equity
Source: Form D, filed Nov 17, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Einziger | Director, Executive |
| Ann Marie Simpson | Director |
Issuer details
Industry: Other (See others in industry)
Address:
3130 Wilshire Blvd., #600
Santa Monica, CA, 90403
Santa Monica, CA, 90403